New York, NY, United States of America

Nodar Kipshidze

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Immunesure LLC, Oncocine, LLC. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nodar Kipshidze. Retrieved from https://idiyas.com/inventor/nodar-kipshidze

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nodar Kipshidze: Innovator in Therapeutic Vaccines

Introduction

Nodar Kipshidze is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of immunology, particularly in the development of therapeutic vaccines. With a total of 2 patents, his work focuses on enhancing immune responses to various diseases.

Latest Patents

Kipshidze's latest patents include "RNA-Based Adjuvant to Enhance the Immune Response to Vaccines and Therapeutics" and "Therapeutic mRNA Vaccine for Malignancies." These innovations aim to improve vaccine efficacy and provide new therapeutic options for patients suffering from malignancies.

Career Highlights

Throughout his career, Nodar Kipshidze has worked with notable companies such as Oncocine, LLC and Immunesure LLC. His expertise in the field has allowed him to contribute to groundbreaking research and development in therapeutic solutions.

Collaborations

Kipshidze has collaborated with talented individuals in his field, including Nickolas Kipshidze and Patrick Iversen. These partnerships have fostered innovation and advancement in therapeutic vaccine research.

Conclusion

Nodar Kipshidze's contributions to the field of immunology and therapeutic vaccines highlight his role as an influential inventor. His work continues to pave the way for advancements in vaccine technology and treatment options for malignancies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…